Capricor Therapeutics | CAPR - Net Income


Capricor Therapeutics reported $-30.17M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 5.55B 1.21B Mar/2026
Cytokinetics USD -206.03M 23M Mar/2026
Geron USD -3.64M 27.5M Mar/2026
Grifols EUR 114.37M 34.03M Dec/2025
Immunic USD -19.3M 6.28M Dec/2025
J&J USD 5.24B 119M Mar/2026
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Prothena USD -21.59M 14.95M Dec/2025
PTC Therapeutics USD -2.81M 132.16M Mar/2026
Sarepta Therapeutics USD 330.96M 743.18M Mar/2026